Document is current
Any future updates will be listed below
-
Authors
Hill, Elliot D. https://orcid.org/0009-0004-1987-3749
Loh, De Rong
Davis, Naomi O.
Goldstein, Benjamin A.
Dawson, Geraldine https://orcid.org/0000-0003-1410-2764
Engelhard, Matthew
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K01-MH127309)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K01-MH127309)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1 TR002553)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1 TR002553)
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 10 March 2026
First Online: 27 April 2026
Competing interests
: G.D. is on the Scientific Advisory Board of Tris Pharma, Inc. Bristol Myers Squibb, YAMO Pharmaceuticals, and the Nonverbal Learning Disability Project, is a consultant for Guidepoint Global, LLC, and receives book royalties from Guilford Press, Oxford University Press and Springer Nature. G.D. reports grant funding from NICHD and NIMH. G.D. has developed technology, data and/or products that have been licensed to Apple, Inc. Both G.D. and Duke University have benefited financially. The remaining authors declare no competing interests.
